Screening compound: C30H35F3N4O6S2 (C071-0567)

Screening compound: C<sub>30</sub>H<sub>35</sub>F<sub>3</sub>N<sub>4</sub>O<sub>6</sub>S<sub>2</sub> (C071-0567)
Screening compound: C<sub>30</sub>H<sub>35</sub>F<sub>3</sub>N<sub>4</sub>O<sub>6</sub>S<sub>2</sub> (C071-0567) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C30H35F3N4O6S2 (C071-0567)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C071-0567

Molecular Formula

C30H35F3N4O6S2 (C30 H35 F3 N4 O6 S2)

Compound Name

6-tert-butyl-2-(4-{[4-(3,4-dimethoxyphenyl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfonyl}butanamido)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

IUPAC name

6-tert-butyl-2-(4-{[4-(34-dimethoxyphenyl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfonyl}butanamido)-4567-tetrahydro-1-benzothiophene-3-carboxamide

SMILES

CC(C)(C)C(CC1)Cc2c1c(C(N)=O)c(NC(CCCS(c1nc(-c(cc3)cc(OC)c3OC)cc(C(F)(F)F)n1)(=O)=O)=O)s2

InChI

InChI=1S/C30H35F3N4O6S2/c1-29(2,3)17-9-10-18-22(14-17)44-27(25(18)26(34)39)37-24(38)7-6-12-45(40,41)28-35-19(15-23(36-28)30(31,32)33)16-8-11-20(42-4)21(13-16)43-5/h8,11,13,15,17H,6-7,9-10,12,14H2,1-5H3,(H2,34,39)(H,37,38)/t17-/m1/s1

InChI Key

BDTWFYHMTVSQMV-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD06164225

C30H35F3N4O6S2 (C071-0567) in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Regenerative Medicine Focused Library (23016 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with C30H35F3N4O6S2 (C071-0567) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C30H35F3N4O6S2 (C071-0567)?
Check Price and Availability of C30H35F3N4O6S2 (C071-0567), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C30H35F3N4O6S2 (C071-0567) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C30H35F3N4O6S2 (C071-0567)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C30H35F3N4O6S2 (C071-0567)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C30H35F3N4O6S2 (C071-0567) available by request